It is a healthcare private not for profit company based in Mumbai, Maharashtra, India, established in 2020.
2020 | Mumbai, Maharashtra, India | ActiveHematology Cancer Consortium - Association, a active private not for profit company, was established on 09 January 2020 in Mumbai, Maharashtra, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85100MH2020NPL335745. Registered under ROC Roc Mumbai. it is unlisted.
It upholds a compliant status. Its leadership includes Vikram (Director), Palani Thyagarajan (Director), Niyati Sutaria James (Director). Past directors included Manju Sengar, Palani Thyagarajan, Niyati Sutaria James. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. 1A, Ground Floor, Deep Co-Operative Housing Society Limited, Jerbai Wadia Road, Parel Bhoiwada, Mumbai, Maharashtra, 400012.
U85100MH2020NPL335745
335745
09 January 2020
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Hematology Cancer Consortium - Association — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikram | Director | 09 Jan 2020 | Current |
| Palani Thyagarajan | Director | 08 Dec 2021 | Current |
| Niyati Sutaria James | Director | 08 Dec 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Dec 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2021 | Past |
| Pramod Abcsdd | Ceo | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hematology Cancer Consortium - Association, for the financial year ended 2023, experienced significant growth in revenue, with a 63.96% increase. The company also saw a substantial fall in profitability, with a 64.29% decrease in profit. The company's net worth Soared by an impressive increase of 11.25%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Hematology Cancer Consortium - Association's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Hematology Cancer Consortium - Association, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hematology Cancer Consortium - Association, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hematology Cancer Consortium - Association's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Hematology Cancer Consortium - Association last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Hematology Cancer Consortium - Association has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Palani Thyagarajan was appointed as a Director was appointed as a Director on 08 Dec 2021 & has been associated with this company since 3 years 11 months . was documented.
The activity Bhavisha Sudarshan Sanadhya was appointed as a CEO was appointed as a CEO on 08 Dec 2021 & has been associated with this company since 3 years 11 months . was completed.
Progress on Niyati Sutaria James was appointed as a Director was appointed as a Director on 08 Dec 2021 & has been associated with this company since 3 years 11 months . was documented.
The activity Vikram was appointed as a Director was appointed as a Director on 09 Jan 2020 & has been associated with this company since 5 years 10 months . was completed.
The CIN of Hematology Cancer Consortium - Association is U85100MH2020NPL335745.
Hematology Cancer Consortium - Association is headquartered at Shop No. 1A, Ground Floor, Deep Co-Operative Housing Society Limited, Jerbai Wadia Road, Parel Bhoiwada, Mumbai, Maharashtra, 400012.
Hematology Cancer Consortium - Association was incorporated on 09 January 2020.
The current directors of Hematology Cancer Consortium - Association are
The primary industry of Hematology Cancer Consortium - Association is Healthcare.
Hematology Cancer Consortium - Association is unlisted.
The compliance status of Hematology Cancer Consortium - Association is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX